Ketazed 0.25 mg/ml
Ketazed 0.25 mg/ml is a medicine authorised by Swissmedic under authorisation number 69003. The authorisation holder is Horus Pharma Suisse SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 January 2024 and the authorisation is limited until 14 January 2029. ATC code S01GX08 places the medicine in the group Ophthalmologicals.
| Authorisation number | 69003 |
|---|---|
| Name | Ketazed 0.25 mg/ml |
| Full name | Ketazed 0.25 mg/ml, Collyre en solution |
| Authorisation holder | Horus Pharma Suisse SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | S01GX08 |
| First authorisation | 15 January 2024 |
| Authorisation validity | 14 January 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ketazed 0.25 mg/ml, Collyre en solution | B | 15 January 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | ml | S01GX08 | 11.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ketazed 0.25 mg/ml authorised in Switzerland?
Yes. Ketazed 0.25 mg/ml is authorised by Swissmedic under authorisation number 69003, data as of 01 September 2026. The authorisation is limited until 14 January 2029.
Which dispensing category does Ketazed 0.25 mg/ml have?
Ketazed 0.25 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ketazed 0.25 mg/ml?
The authorisation holder is Horus Pharma Suisse SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.